Title : Resistance to BTK inhibition by ibrutinib can be overcome by preventing FOXO3a nuclear export and PI3K/AKT activation in B-cell lymphoid malignancies.

Pub. Date : 2019 Dec 4

PMID : 31801949






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Resistance to BTK inhibition by ibrutinib can be overcome by preventing FOXO3a nuclear export and PI3K/AKT activation in B-cell lymphoid malignancies. ibrutinib AKT serine/threonine kinase 1 Homo sapiens
2 Inhibition of PI3K and AKT using idelalisib and MK2206, respectively increased ibrutinib-induced apoptosis in IB-R cells by downregulation of pAKT473 and restoring FOXO3a levels, demonstrating the importance of these cell survival factors for ibrutinib-resistance. ibrutinib AKT serine/threonine kinase 1 Homo sapiens
3 Inhibition of PI3K and AKT using idelalisib and MK2206, respectively increased ibrutinib-induced apoptosis in IB-R cells by downregulation of pAKT473 and restoring FOXO3a levels, demonstrating the importance of these cell survival factors for ibrutinib-resistance. ibrutinib AKT serine/threonine kinase 1 Homo sapiens